Health IT Analytics September 30, 2022
Shania Kennedy

Louisiana State University Health New Orleans is partnering with ConcertAI to address access to and diversity in cancer clinical trials.

The National Cancer Institute Community Oncology Research Program (NCI NCORP)-designated Louisiana State University (LSU) Health New Orleans is collaborating with artificial intelligence (AI) and real-world data solutions company ConcertAI to improve diversity in clinical trials and ensure broader access for cancer patients.

The collaboration is part of ongoing work by LSU Health New Orleans and NCI NCORP to establish and improve the clinical trials network in the Gulf South region. According to the press release, NCI awarded LSU Health New Orleans a $5.6 million grant to create the network and another $13.6 million to expand it, with an emphasis on reaching...

Today's Sponsors

LEK
Teladoc Health
Amwell

Today's Sponsors

LEK
Teladoc Health

Today's Sponsor

Oliver Wyman

 
Topics: AI (Artificial Intelligence), Clinical Trials, Equity/SDOH, Health System / Hospital, Healthcare System, Partnerships, Provider, Technology, Trends
Lokavant raises $21M for clinical trial data platform
How a new investment is powering a revolution in clinical trial operations
How Virtual-First Clinical Trials Scale Access for Participants
We must improve diversity in clinical trials. These 5 steps will help.
Vial raises $67M for clinical trial tech and more digital health fundings